366 related articles for article (PubMed ID: 20839285)
1. Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system.
Leslie WD; Lix LM;
J Bone Miner Res; 2011 Mar; 26(3):460-7. PubMed ID: 20839285
[TBL] [Abstract][Full Text] [Related]
2. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
3. Imputation of 10-year osteoporotic fracture rates from hip fractures: a clinical validation study.
Leslie WD; Lix LM;
J Bone Miner Res; 2010 Feb; 25(2):388-92. PubMed ID: 19653809
[TBL] [Abstract][Full Text] [Related]
4. Single-site vs multisite bone density measurement for fracture prediction.
Leslie WD; Lix LM; Tsang JF; Caetano PA;
Arch Intern Med; 2007 Aug 13-27; 167(15):1641-7. PubMed ID: 17698687
[TBL] [Abstract][Full Text] [Related]
5. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
Leslie WD; Tsang JF; Lix LM
Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
[TBL] [Abstract][Full Text] [Related]
6. Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement.
Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Osteoporos Int; 2011 Mar; 22(3):839-47. PubMed ID: 20959961
[TBL] [Abstract][Full Text] [Related]
7. [The fracture risk assessment tool (FRAXTM), where are we in Tunisia?].
Zrour-Hassen S; Jguirim M; Guezguez M; Mnif H; Younes M; Bejia I; Touzi M; Abid A; Essabah H; Bergaoui N
Tunis Med; 2011 Feb; 89(2):136-41. PubMed ID: 21308620
[TBL] [Abstract][Full Text] [Related]
8. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
9. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
[TBL] [Abstract][Full Text] [Related]
10. Fracture prediction from bone mineral density in Japanese men and women.
Fujiwara S; Kasagi F; Masunari N; Naito K; Suzuki G; Fukunaga M
J Bone Miner Res; 2003 Aug; 18(8):1547-53. PubMed ID: 12929946
[TBL] [Abstract][Full Text] [Related]
11. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.
Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
J Bone Miner Res; 2010 Nov; 25(11):2350-8. PubMed ID: 20499367
[TBL] [Abstract][Full Text] [Related]
12. Nonstandard Lumbar Region in Predicting Fracture Risk.
Alajlouni D; Bliuc D; Tran T; Pocock N; Nguyen TV; Eisman JA; Center JR
J Clin Densitom; 2018; 21(2):220-226. PubMed ID: 28689879
[TBL] [Abstract][Full Text] [Related]
13. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
Watts NB; Geusens P; Barton IP; Felsenberg D
J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
[TBL] [Abstract][Full Text] [Related]
15. Impact of spine-hip discordance on fracture risk assessment and treatment qualification in Canada: the Manitoba BMD registry.
Leslie WD; Morin SN; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):85. PubMed ID: 32514615
[TBL] [Abstract][Full Text] [Related]
16. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures.
Giangregorio LM; Leslie WD;
J Bone Miner Res; 2010 Jun; 25(6):1400-5. PubMed ID: 20200950
[TBL] [Abstract][Full Text] [Related]
17. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study.
Schoofs MW; van der Klift M; Hofman A; van Duijn CM; Stricker BH; Pols HA; Uitterlinden AG
J Bone Miner Res; 2004 Sep; 19(9):1490-6. PubMed ID: 15312249
[TBL] [Abstract][Full Text] [Related]
18. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
[TBL] [Abstract][Full Text] [Related]
19. Number of osteoporotic sites and fracture risk assessment: a cohort study from the Manitoba Bone Density Program.
Leslie WD; Tsang JF; Caetano PA; Lix LM;
J Bone Miner Res; 2007 Mar; 22(3):476-83. PubMed ID: 17144788
[TBL] [Abstract][Full Text] [Related]
20. Simplified 10-year absolute fracture risk assessment: a comparison of men and women.
Leslie WD; Lix LM;
J Clin Densitom; 2010; 13(2):141-6. PubMed ID: 20435264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
